Cargando…
Ethnic delineation of primary glioblastoma genome
Glioblastoma (GBM) is the most malignant primary brain tumor in adults with substantial genomic alterations. The median survival is approximately 14.6 months, despite aggressive therapeutic intervention, which comprised of surgical resection, radiotherapy, and chemotherapy. Recent studies on cancer...
Autores principales: | Koo, Harim, Choi, Seung Won, Cho, Hee Jin, Lee, In‐Hee, Kong, Doo‐Sik, Seol, Ho Jun, Lee, Jung‐Il, Choi, Jung‐Won, Sa, Jason K., Nam, Do‐Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541127/ https://www.ncbi.nlm.nih.gov/pubmed/32794373 http://dx.doi.org/10.1002/cam4.3370 |
Ejemplares similares
-
Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma
por: Choi, Seung Won, et al.
Publicado: (2018) -
Analysis of risk factors to predict communicating hydrocephalus following gamma knife radiosurgery for intracranial schwannoma
por: Lee, Seunghoon, et al.
Publicado: (2016) -
Hypermutagenesis in untreated adult gliomas due to inherited mismatch mutations
por: Sa, Jason K., et al.
Publicado: (2019) -
Multi-Habitat Radiomics Unravels Distinct Phenotypic Subtypes of Glioblastoma with Clinical and Genomic Significance
por: Choi, Seung Won, et al.
Publicado: (2020) -
Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma
por: Kim, Nalee, et al.
Publicado: (2023)